Each article is made available under the terms of the Creative Commons Attribution Non-Commercial License. ​All of our articles are available to download individually in PDF format.


New Drug Treatments for Osteoarthritis: What is on the Horizon?

New Drug Treatments for Osteoarthritis: What is on the Horizon?

March 2, 2017 at 8:24 AM 0 comments

*Fiona E. Watt,1 Malvika Gulati2 1. Arthritis Research UK Centre for Osteoarthritis Pathogenesis, Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK 2. Department of Rheumatology, Royal Free Hospital, London, UK *Correspondence to fiona.watt@kennedy.ox.ac.uk Disclosure: The authors have declared no conflicts of interest. Support:Read More

Antiphospholipid Syndrome and the Lungs

Antiphospholipid Syndrome and the Lungs

March 2, 2017 at 8:21 AM 0 comments

*Süreyya Yılmaz,1 Zülfükar Yılmaz2 1. Department of Chest Diseases, Faculty of Medicine, Dicle University, Diyarbakir, Turkey 2. Department of Internal Medicine, Faculty of Medicine, Dicle University, Diyarbakir, Turkey *Correspondence to sureyyayilm@gmail.com Disclosure: The authors have declared no conflicts of interest. Received: 08.02.16 Accepted: 06.06.16 Citation: EMJ. 2017;2[1]:76-82. Abstract Antiphospholipid syndromeRead More

Epigenetic Mechanisms in Sjögren’s Syndrome

Epigenetic Mechanisms in Sjögren’s Syndrome

December 19, 2016 at 4:10 PM 0 comments

Christelle Le Dantec,1 Amandine Charras,1 Anne Bordron,1 Wesley H. Brooks,2 *Yves Renaudineau1,3 1. INSERM ESPRI, ERI29/EA2216, LabEx IGO “Immunotherapy Graft Oncology”, Innovative Medicines Initiative PRECISESADS, Réseau épigénétique et réseau canaux ioniques du Cancéropole Grand Ouest, European University of Brittany, Brest, France 2. Department of Chemistry, University of South Florida, Tampa, Florida, USARead More

The Evolving Landscape of Rheumatology: Biosimilarity and Extrapolation

The Evolving Landscape of Rheumatology: Biosimilarity and Extrapolation

August 26, 2016 at 8:30 AM 0 comments

This symposium took place on 9th June 2016, as part of the European League Against Rheumatism (EULAR) Congress 2016 in London, UK Chairperson: Peter Taylor1 Speakers: Emily Shacter,2 Craig Leonardi,3 Peter Taylor1 1. Kennedy Institute of Rheumatology, Oxford University, Oxford, UK 2. ThinkFDA, LLC, Washington DC, USA 3. Department ofRead More

Introducing New Biosimilars Into Current Treatment Algorithms

Introducing New Biosimilars Into Current Treatment Algorithms

July 26, 2016 at 8:30 AM 0 comments

Summary of a Biogen-sponsored symposium, held at the European League Against Rheumatism (EULAR) Congress 2016 in London, UK, on 9th June 2016 Moderator: John D. Isaacs1 Faculty: Thomas Dörner,2 Tore K. Kvien,3 Arnold Vulto4 1. Institute of Cellular Medicine, Newcastle University, Newcastle, UK 2. Department of Rheumatology and Clinical Immunology,Read More

Optimising Patient Outcomes Throughout the Rheumatoid Arthritis Patient Journey: The Exception, the Standard, and the Rule

Optimising Patient Outcomes Throughout the Rheumatoid Arthritis Patient Journey: The Exception, the Standard, and the Rule

July 26, 2016 at 8:29 AM 0 comments

This satellite symposium took place on 10th June 2016, as a part of the European League Against Rheumatism (EULAR) 17th annual congress in London, UK Chairperson: Peter Taylor1 Speakers: Ronald van Vollenhoven,2 Peter Taylor,1 Daniel Aletaha3 1. University of Oxford, Botnar Research Centre, Oxford, UK 2. Amsterdam Rheumatology and ImmunologyRead More

Unravelling the Mystery Between Structure and Sustained Clinical Outcomes

Unravelling the Mystery Between Structure and Sustained Clinical Outcomes

July 26, 2016 at 8:28 AM 0 comments

This symposium took place on 9th June 2016 as a part of the European League Against Rheumatism (EULAR) Congress 2016 in London, UK Chairperson: Edward Keystone1 Speakers: Edward Keystone,1 Leigh Revers,2 Thomas Dörner,3 1. Toronto General Research Institute, Toronto, Canada 2. University of Toronto, Toronto, Canada 3. Charité – UniversityRead More

Precision Medicine: Maximising Treatment Benefit for Rheumatoid Arthritis Patients

Precision Medicine: Maximising Treatment Benefit for Rheumatoid Arthritis Patients

July 26, 2016 at 8:27 AM 0 comments

This symposium took place on 9th June 2016 as part of the European League Against Rheumatism (EULAR) Congress 2016 in London, UK Chairperson: Ernest Choy1 Speakers: Ernest Choy,1 Eric Ruderman,2 Cem Gabay,3 Georg Schett4 1. Cardiff University School of Medicine and University Hospital of Wales, Cardiff, UK 2. Northwestern UniversityRead More

Think Rheumatoid Arthritis: Causes, Consequences, and Management

Think Rheumatoid Arthritis: Causes, Consequences, and Management

July 26, 2016 at 8:26 AM 0 comments

This satellite symposium took place on 9th June 2016, as a part of the European League Against Rheumatism (EULAR) 17th annual congress in London, UK Chairpersons: Josef Smolen,1 Costantino Pitzalis2 Speakers: Josef Smolen,1 Costantino Pitzalis,2 Simon Jones,3 Frank McKenna4 1. Medical University of Vienna and Hietzing Hospital, Vienna, Austria 2.Read More

Editor’s Pick: TYRO3, AXL, and MERTK Receptor Tyrosine Kinases: Is There Evidence of Direct Involvement in Development and Onset of Sjögren’s Syndrome?

Editor’s Pick: TYRO3, AXL, and MERTK Receptor Tyrosine Kinases: Is There Evidence of Direct Involvement in Development and Onset of Sjögren’s Syndrome?

July 26, 2016 at 8:25 AM 0 comments

Diagnosis of Sjögren’s syndrome has been made difficult as it exhibits a similar symptomatology to other autoimmune conditions. This is just one aspect of the disorder that has frustrated attempts to better understand its genetic, environmental, and immunological basis. In the following paper, Wanchoo et al. provide some welcome headwayRead More